SAILIFE — SAI Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹236.25bn
- IN₹236.52bn
- IN₹21.92bn
Annual cashflow statement for SAI Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 97 | 164 | 1,092 | 2,277 | 4,662 |
| Depreciation | |||||
| Non-Cash Items | 377 | 727 | 865 | 1,005 | -112 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -327 | 308 | -521 | -1,527 | -1,127 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,049 | 2,194 | 2,631 | 3,140 | 5,091 |
| Capital Expenditures | -2,069 | -1,131 | -1,817 | -3,693 | -5,930 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,032 | 113 | -107 | -1,674 | 1,976 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,037 | -1,018 | -1,924 | -5,367 | -3,954 |
| Financing Cash Flow Items | -501 | -785 | -853 | -887 | -538 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 719 | -2,006 | -953 | 3,014 | -1,237 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 752 | -802 | -236 | 791 | -91.4 |